200 related articles for article (PubMed ID: 32457420)
1. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak.
Boisen ML; Uyigue E; Aiyepada J; Siddle KJ; Oestereich L; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Eromon P; Kayode AT; Odia I; Adomeh DI; Muoebonam EB; Akhilomen P; Okonofua G; Osiemi B; Omoregie O; Airende M; Agbukor J; Ehikhametalor S; Aire CO; Duraffour S; Pahlmann M; Böhm W; Barnes KG; Mehta S; Momoh M; Sandi JD; Goba A; Folarin OA; Ogbaini-Emovan E; Asogun DA; Tobin EA; Akpede GO; Okogbenin SA; Okokhere PO; Grant DS; Schieffelin JS; Sabeti PC; Günther S; Happi CT; Branco LM; Garry RF
Sci Rep; 2020 May; 10(1):8724. PubMed ID: 32457420
[TBL] [Abstract][Full Text] [Related]
2. Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.
Boisen ML; Hartnett JN; Shaffer JG; Goba A; Momoh M; Sandi JD; Fullah M; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Koval AP; Cross RW; Barnes KG; Lachenauer AE; Lin AE; Nekoui M; Kotliar D; Winnicki SM; Siddle KJ; Gbakie M; Fonnie M; Koroma VJ; Kanneh L; Kulakosky PC; Hastie KM; Wilson RB; Andersen KG; Folarin OO; Happi CT; Sabeti PC; Geisbert TW; Saphire EO; Khan SH; Grant DS; Schieffelin JS; Branco LM; Garry RF
Sci Rep; 2018 Apr; 8(1):5939. PubMed ID: 29651117
[TBL] [Abstract][Full Text] [Related]
3. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.
Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF
Virol J; 2011 Aug; 8():404. PubMed ID: 21843352
[TBL] [Abstract][Full Text] [Related]
4. Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.
Heinrich ML; Boisen ML; Nelson DKS; Bush DJ; Cross RW; Koval AP; Hoffmann AR; Beddingfield BJ; Hastie KM; Rowland MM; Aimukanova I; Koval S; Lathigra R; Borisevich V; Momoh M; Sandi JD; Goba A; Odia L; Baimba F; Aiyepada JO; Ebo B; Eromon P; Ugwu C; Folarin O; Olumade T; Onyechi MN; Etafo J; Adeyemi R; Ella EE; Aminu M; Gomerep SS; Eke MA; Ogunsanya O; Akpede GO; Asogun DO; Okogbenin SA; Okokhere PO; Holst J; Shaffer JG; Schieffelin JS; Geisbert TW; Saphire EO; Happi CT; Grant DS; Garry RF; Branco LM
Sci Rep; 2020 Sep; 10(1):16030. PubMed ID: 32994446
[TBL] [Abstract][Full Text] [Related]
5. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection.
Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF
Virol J; 2011 Oct; 8():478. PubMed ID: 22023795
[TBL] [Abstract][Full Text] [Related]
6. Identification of Common CD8
Sakabe S; Hartnett JN; Ngo N; Goba A; Momoh M; Sandi JD; Kanneh L; Cubitt B; Garcia SD; Ware BC; Kotliar D; Robles-Sikisaka R; Gangavarapu K; Branco LM; Eromon P; Odia I; Ogbaini-Emovon E; Folarin O; Okogbenin S; Okokhere PO; Happi C; Sabeti PC; Andersen KG; Garry RF; de la Torre JC; Grant DS; Schieffelin JS; Oldstone MBA; Sullivan BM
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269122
[TBL] [Abstract][Full Text] [Related]
7. Lassa fever in post-conflict sierra leone.
Shaffer JG; Grant DS; Schieffelin JS; Boisen ML; Goba A; Hartnett JN; Levy DC; Yenni RE; Moses LM; Fullah M; Momoh M; Fonnie M; Fonnie R; Kanneh L; Koroma VJ; Kargbo K; Ottomassathien D; Muncy IJ; Jones AB; Illick MM; Kulakosky PC; Haislip AM; Bishop CM; Elliot DH; Brown BL; Zhu H; Hastie KM; Andersen KG; Gire SK; Tabrizi S; Tariyal R; Stremlau M; Matschiner A; Sampey DB; Spence JS; Cross RW; Geisbert JB; Folarin OA; Happi CT; Pitts KR; Geske FJ; Geisbert TW; Saphire EO; Robinson JE; Wilson RB; Sabeti PC; Henderson LA; Khan SH; Bausch DG; Branco LM; Garry RF;
PLoS Negl Trop Dis; 2014 Mar; 8(3):e2748. PubMed ID: 24651047
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of diagnostic tests for Lassa fever: a systematic review.
Takah NF; Brangel P; Shrestha P; Peeling R
BMC Infect Dis; 2019 Jul; 19(1):647. PubMed ID: 31324229
[TBL] [Abstract][Full Text] [Related]
9. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues.
Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220
[TBL] [Abstract][Full Text] [Related]
10. Development of an RT-LAMP assay for the detection of Lassa viruses in southeast and south-central Nigeria.
Pemba CM; Kurosaki Y; Yoshikawa R; Oloniniyi OK; Urata S; Sueyoshi M; Zadeh VR; Nwafor I; Iroezindu MO; Ajayi NA; Chukwubike CM; Chika-Igwenyi NM; Ndu AC; Nwidi DU; Maehira Y; Unigwe US; Ojide CK; Onwe EO; Yasuda J
J Virol Methods; 2019 Jul; 269():30-37. PubMed ID: 30974179
[TBL] [Abstract][Full Text] [Related]
11. Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria.
Ogunro BN; Olugasa BO; Kayode A; Ishola OO; Kolawole ON; Odigie EA; Happi C
J Epidemiol Glob Health; 2019 Jun; 9(2):125-127. PubMed ID: 31241870
[TBL] [Abstract][Full Text] [Related]
12. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.
Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK;
PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation.
Asogun DA; Adomeh DI; Ehimuan J; Odia I; Hass M; Gabriel M; Olschläger S; Becker-Ziaja B; Folarin O; Phelan E; Ehiane PE; Ifeh VE; Uyigue EA; Oladapo YT; Muoebonam EB; Osunde O; Dongo A; Okokhere PO; Okogbenin SA; Momoh M; Alikah SO; Akhuemokhan OC; Imomeh P; Odike MA; Gire S; Andersen K; Sabeti PC; Happi CT; Akpede GO; Günther S
PLoS Negl Trop Dis; 2012; 6(9):e1839. PubMed ID: 23029594
[TBL] [Abstract][Full Text] [Related]
14. Lassa Fever Natural History and Clinical Management.
Grant DS; Samuels RJ; Garry RF; Schieffelin JS
Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159
[TBL] [Abstract][Full Text] [Related]
15. Differential pathogenesis of closely related 2018 Nigerian outbreak clade III Lassa virus isolates.
Stein DR; Warner BM; Audet J; Soule G; Siragam V; Sroga P; Griffin BD; Leung A; Grolla A; Tierney K; Albietz A; Kobasa D; Musa AS; Ahmad A; Akinpelu AM; Mba N; Rosenke R; Scott DP; Saturday G; Ihekweazu C; Safronetz D
PLoS Pathog; 2021 Oct; 17(10):e1009966. PubMed ID: 34634087
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G.
Gabriel M; Adomeh DI; Ehimuan J; Oyakhilome J; Omomoh EO; Ighodalo Y; Olokor T; Bonney K; Pahlmann M; Emmerich P; Lelke M; Brunotte L; Ölschläger S; Thomé-Bolduan C; Becker-Ziaja B; Busch C; Odia I; Ogbaini-Emovon E; Okokhere PO; Okogbenin SA; Akpede GO; Schmitz H; Asogun DA; Günther S
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006361. PubMed ID: 29596412
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
[TBL] [Abstract][Full Text] [Related]
18. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.
Maruyama J; Manning JT; Mateer EJ; Sattler R; Bukreyeva N; Huang C; Paessler S
mSphere; 2019 Sep; 4(5):. PubMed ID: 31554720
[TBL] [Abstract][Full Text] [Related]
19. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.
Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF
Virol J; 2010 Nov; 7():306. PubMed ID: 21062490
[TBL] [Abstract][Full Text] [Related]
20. Adaptive genetic diversification of Lassa virus associated with the epidemic split of north-central Nigerian and non-Nigerian lineages.
Li Y; Tian H
Virology; 2020 Jun; 545():10-15. PubMed ID: 32174454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
